Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | PBYI | XFOR | ||
| Company | Lineage Cell Therapeutics Inc | Puma Biotechnology | X4 Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 1.5000 | 7.46 | 4.15 | ||
| High | 1.5160 | 7.70 | 4.30 | ||
| Low | 1.4000 | 7.41 | 4.13 | ||
| Latest | 1.4200 | 7.53 | 4.21 | ||
| Change | -0.1100 | +0.04 | +0.02 | ||
| % Change | -7.19% | +0.53% | +0.48% | ||
| Volume | 2,768,700 | 326,900 | 305,700 | ||
| 20-Day Average Volume | 1,234,765 | 259,865 | 400,620 | ||
| Previous Close | 1.5300 | 7.49 | 4.19 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5585 | 7.47 | 4.16 | ||
| 20-Day Raw Stochastic | 5.71% | 71.41% | 53.13% | ||
| 20-Day Relative Strength | 40.35 | 59.28 | 52.65 | ||
| Weighted Alpha | +88.72 | +98.82 | -5.13 | ||
| Today's Opinion | 72% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 80% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.39% since 04/27/26 | +0.27% since 04/27/26 | unch since 04/27/26 | ||
| Low | 1.4000 on 05/04/26 | 7.33 on 05/01/26 | 3.97 on 04/29/26 | ||
| High | 1.6600 on 04/28/26 | 7.73 on 04/28/26 | 4.30 on 05/04/26 | ||
| 1-Month | |||||
| %Chg | -9.55% since 04/02/26 | +9.13% since 04/02/26 | -0.71% since 04/02/26 | ||
| Low | 1.4000 on 05/04/26 | 6.61 on 04/07/26 | 3.70 on 04/07/26 | ||
| High | 1.7500 on 04/17/26 | 7.90 on 04/10/26 | 4.66 on 04/23/26 | ||
| 3-Month | |||||
| %Chg | -18.39% since 02/04/26 | +6.06% since 02/04/26 | +9.35% since 02/04/26 | ||
| Low | 1.4000 on 05/04/26 | 5.50 on 03/02/26 | 2.83 on 02/18/26 | ||
| High | 1.9850 on 03/02/26 | 7.90 on 04/10/26 | 4.83 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | -21.11% since 11/04/25 | +53.67% since 11/04/25 | +6.05% since 11/04/25 | ||
| Low | 1.4000 on 05/04/26 | 4.57 on 11/11/25 | 2.83 on 02/18/26 | ||
| High | 1.9900 on 11/13/25 | 7.90 on 04/10/26 | 4.83 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,105 | 381,181 | 380,955 | ||
| Shares Outstanding, K | 249,088 | 50,892 | 90,920 | ||
| Annual Sales | 14,560,000 | 228,370,000 | 35,110,000 | ||
| Annual Net Income | -63,530,000 | 31,110,000 | -79,200,000 | ||
| Last Quarter Sales | 6,610,000 | 75,450,000 | 2,570,000 | ||
| Last Quarter Net Income | 850,000 | 13,440,000 | -23,930,000 | ||
| 60-Month Beta | 1.60 | 1.24 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/05/26 | 0.29 on 02/26/26 | -0.22 on 03/17/26 | ||
| Earnings Date | 05/12/26 | 05/07/26 | 05/07/26 | ||
| Most Recent Dividend | 0.080 on 12/15/03 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.31 | 0.00 | ||